Biotech company with in-house R&D and Swedish production

With two manufacturing plants in Sweden and a large share of biomaterial research and mechanistic studies performed at Karolinska Institute in Stockholm, biotech company Nordberg Medical upholds rigorous standards at every stage of its operations—from research to production. Here is how we ensure high-quality products for patients.

Quality embedded throughout the value chain

At the core of Nordberg Medical’s operations is innovative biotechnology design. The proprietary LASYNPRO^TM microsphere technology has a proven mode of action in regenerating collagen^1,2 and is unique to the collagen biostimulator JULÄINE™.¹
The technological advances are the result of biomedical expertise, careful formulation, and a deep understanding of the skin’s natural architecture.
A significant portion of research and development takes place in Stockholm, while the two manufacturing plants are located in the Swedish cities of Uppsala and Malmö. Quality is embedded throughout the entire value chain.

Seamless operations

At the two production sites, precision guides every stage, from material preparation to final packaging. Carefully defined protocols ensure consistency, safety, and quality.
Sander den Hoed, Project Manager at Nordberg Medical, is in charge of production and brings extensive experience from the pharmaceutical industry, LEAN manufacturing, risk management, as well as design, installation, and operational qualification (DQ/IQ/OQ).
“Quality is not an added layer; it’s simply how we operate. It may not look complex at first glance, but the level of detail behind producing every vial of JULÄINE™ is remarkable. The real achievement is how all the technical elements come together so seamlessly,” comments Sander den Hoed.
While many production steps are automated, Sander den Hoed’s role is to maintain momentum, anticipate challenges, and ensure his team has the right conditions to succeed.

Close collaboration between functions

Biotechnology production is highly complex and medical devices are governed by comprehensive regulatory frameworks. JULÄINE™ falls under Class III medical devices, representing the strictest requirements within the EU.
Much of this complexity is invisible for an outsider. Yet, for the teams in development and production, the technical proficiency is unmistakable. Collaboration plays an essential role. By working closely across functions, the team creates an environment where focus, accountability, and mutual support drive progress forward.
“People here take their work seriously because they understand why it matters. Everyone gives their best. Not just to complete the task, but to do it right. We support each other, stay focused, and take pride in what we create,” says Sander den Hoed.

Positioned to meet future demands

There is a strong global trend toward health and longevity. Aesthetic consumers increasingly seek treatments that deliver natural-looking results and a healthy appearance.³ Nordberg Medical is well positioned to meet this rising demand and is quickly expanding into new markets, with sales experiencing rapid and sustained growth. Sander den Hoed’s current focus is to secure production capacity to meet the growing global demand.
Nordberg Medical is expanding and has obtained a license to market the LASYNPRO™ technology in more than 35 markets. Please contact us if you have any product or market enquiries.

Are you interested in working for a biotech company that pioneers high quality solutions? Please visit the careers section to see our job openings.